Robert Jordan dies at age 58
Charleston writer had international fame
By Bill Thompson
Charleston novelist James Oliver Rigney Jr., 58, known to millions of readers by the pen name Robert Jordan, the best-selling author of "The Wheel of Time" fantasy series, died Sunday after a fight with the rare blood disease amyloidosis, a progressive disorder first diagnosed in December 2005 at the Medical University of South Carolina.
Rigney, who also wrote novels under the nom de plume Reagan O'Neal, succumbed to complications from primary amyloidosis with cardiomyopathy.
In an open letter to the science fiction magazine Locus in April of 2006, Rigney said he had been diagnosed with a disorder that affects only eight people out of one million each year.
The most popular fantasy author since J.R.R. Tolkien, Rigney was born in 1948 in Charleston. A graduate of The Citadel who earned a degree in physics, he served two tours of duty in Vietnam with the U.S. Army, winning a Distinguished Flying Cross, the Bronze Star and two Vietnamese Crosses of Gallantry. A lifelong history buff and voracious reader, he also wrote dance and theater criticism. He had been writing full time since 1977.
His "Wheel of Time" series was among the best-selling in the history of fantasy publishing, with thousands of Web sites devoted in whole or in part to his writing. He also wrote many of the popular "Conan the Barbarian" books, picking up from series creator Robert E. Howard.
A note published on his blog, www.dragonmount.com, announcing his death continued to fill up with comments from fans from across the globe Sunday night as word spread.
At the time of his death, Rigney was one of the leading lights of the Lowcountry literary community. Along with outdoor activities, he liked playing poker and chess and collecting hats and pipes.
He is survived by his wife, Harriet McDougal Rigney.
Funeral arrangements will be announced later this week.
Reach Bill Thompson at 937-5707 or at bthompson@postandcourier.com
Comments
Native_Ink (anonymous) says...
My condolences to the family. Robert Jordan displayed enormous talent and a truly epic vision in his work, and he will be missed.
September 17, 2007 at 8:45 a.m. ( permalink | suggest removal )
megaward (anonymous) says...
R.I.P. James
September 17, 2007 at 11:30 a.m. ( permalink | suggest removal )
JamesH (anonymous) says...
Our deepest sympathy to the family and friends of this great writer. Does anyone know of "amyloidosis" society, that would take donations for research like the Cancer Society?
September 17, 2007 at 1:44 p.m. ( permalink | suggest removal )
Muriel (anonymous) says...
The Cancer Society is wonderful but the Amyloidosis Research at Mayo Clinic where he was treated
Go to www.amyloidosissupport.com and see medical links....
Muriel
Amyloidosis Support Groups Inc.
ASG www.amyloidosissupport.com
Toll Free 866-404-7539
September 17, 2007 at 2:15 p.m. ( permalink | suggest removal )
Muriel (anonymous) says...
Hematological Malignancies at Mayo Clinic
200 First St SW
Attn: Dr. Morie Gertz
In Memory of Robert Jordan
Rochester Minnesota 55902
September 17, 2007 at 3:46 p.m. ( permalink | suggest removal )
Postandcourier.com is pleased to offer readers the enhanced ability to comment on stories. We expect our readers to engage in lively, yet civil discourse. Postandcourier.com does not edit user submitted statements and we cannot promise that readers will not occasionally find offensive or inaccurate comments posted in the comments area. Responsibility for the statements posted lies with the person submitting the comment, not postandcourier.com. If you find a comment that is objectionable, please click "report abuse" and we will review it for possible removal. Please be reminded, however, that in accordance with our Terms of Use and federal law, we are under no obligation to remove any third party comments posted on our website.
Users can now build user-to-user connections, follow friends' recent posts, add an avatar that fits their personality, and more. If you have posted here before you'll need to sign up again, or if you've never posted before, start now by signing up!
Full terms and conditions can be read here.
Thank you for your interest in this story. The comment thread for this article has been closed.
- Most Commented
- Most Emailed

